Nimesh A. Patel - research works

Retinal procedures required 76.1 minutes vs 20.8 minutes for cataract surgery (ratio, 3.65).

Time-normalized metrics favored cataract surgery, with reimbursement, cost, and profits per minute of $52.63, $29.28, and $23.35, compared with retinal procedures' $24.61, $16.22, and $8.40.

The financial efficiency coefficient was 0.098, indicating retinal surgery was less than 10% efficient after adjusting for operative duration.

Parity would require reducing operative time to 7.5 minutes or increasing reimbursement by $61.05 per minute (~71%).

Techniques for haptic externalization included 30g needles (57%), 27g needles (14%), and 27g pars plana vitrectomy ports (29%).

In 20 of 21 eyes (95%), tilt occurred spontaneously.

The median interval between IOL implantation to detection of tilt was 10 days (range: 1 - 1086 days, IQR: 1 - 74 days), and the median interval between tilt detection and corrective intervention was 75 days (range: 6 - 946 days, IQR: 21 - 197 days).

The rate of endophthalmitis was significantly higher for corticosteroid implants and pegcetacoplan compared to anti-VEGF injections.

Sixteen (8.8%) required early retreatment at a median postmenstrual age (PMA) of 40.4 weeks (IQR, 38.44-43.3).

There were differences in the proportion of early retreated infants (21.5% for laser vs 1.7% for injection, P < .001).

The median PMA at late retreatment was 45.6 weeks (IQR, 43.7-47.4).

Similarly, patients in the bevacizumab group had lower odds of requiring early retreatment compared to those with laser (OR, 0.08; 95% CI, 0.04-0.18).

The incidence of endophthalmitis was 0.097% (1 case per 1031 procedures) after vitrectomy for retinal detachment, 0.1% for trabeculectomy (1 case per 1000 procedures), 0.075% for tube shunts (1 case per 1333 procedures), and 0.068% for scleral buckle surgery (1 case per 1459 procedures).

The incidence after cataract surgery was 0.038% (1 case per 2652 procedures), 0.039% (1 case per 2551 procedures) after standalone minimally invasive glaucoma surgery, 0.02% (1 case per 5013 procedures) after goniotomy, and 0.011% for strabismus surgery (1 case per 9091 procedures).